(Q37962101)

26 August 2017

title

Drug interaction in psycho-oncology: antidepressants and antineoplastics (English)

1 reference

26 August 2017

C Miguel

1

1 reference

26 August 2017

E Albuquerque

series ordinal

2

1 reference

26 August 2017

publication date

26 November 2011

1 reference

26 August 2017

1 reference

26 August 2017

volume

88

1 reference

26 August 2017

issue

5-6

1 reference

26 August 2017

page(s)

333-339

1 reference

Detection and treatment of depressive and anxiety disorders among cancer patients: feasibility and preliminary findings from a liaison service in an oncology division.

26 August 2017

cites work

1 reference

Prevalence of depression in patients with cancer

21 January 2018

1 reference

Clinical experience of the use of a pharmacological treatment algorithm for major depressive disorder in patients with advanced cancer.

21 January 2018

1 reference

The development of evidence-based European guidelines on the management of depression in palliative cancer care

21 January 2018

1 reference

Treatment of depression in cancer patients

21 January 2018

1 reference

Pharmacokinetic drug interactions of new antidepressants: a review of the effects on the metabolism of other drugs

21 January 2018

1 reference

The pharmacological importance of cytochrome CYP3A4 in the palliation of symptoms: review and recommendations for avoiding adverse drug interactions

21 January 2018

1 reference

Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study

21 January 2018

1 reference

Interactions between tamoxifen and antidepressants via cytochrome P450 2D6.

21 January 2018

1 reference

Pharmacogenomics--drug disposition, drug targets, and side effects

21 January 2018

1 reference

Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes

21 January 2018

1 reference

Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen

21 January 2018

1 reference

Impact of CYP2D6*10 on recurrence-free survival in breast cancer patients receiving adjuvant tamoxifen therapy

21 January 2018

1 reference

Association between CYP2D6 *10 genotype and survival of breast cancer patients receiving tamoxifen treatment.

21 January 2018

1 reference

CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment

21 January 2018

1 reference

Inhibitory effects of tricyclic antidepressants (TCAs) on human cytochrome P450 enzymes in vitro: mechanism of drug interaction between TCAs and phenytoin

21 January 2018

1 reference

Sertraline is metabolized by multiple cytochrome P450 enzymes, monoamine oxidases, and glucuronyl transferases in human: an in vitro study

21 January 2018

1 reference

Lack of interaction of milnacipran with the cytochrome p450 isoenzymes frequently involved in the metabolism of antidepressants

21 January 2018

1 reference

Depression as a Prognostic Factor for Breast Cancer Mortality

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000334738

1 reference

26 August 2017

1 reference